Back

Apolipoprotein b discordance at very low low-density lipoprotein cholesterol thresholds: a patient-level analysis

29 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Lipoproteins and coronary artery disease (1) Lipids ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Johannes Bernhard

Medical University of Vienna, Vienna (Austria)

5 More presentations in this session

Presentation thumbnail
Prevalence and impact of a pathogenic CYP27A1 variant on phenotypes among patients with monogenic heterozygous familial hypercholesterolemia
Doctor H. Tada (Kanazawa, JP)
Abstract Slides Video
Presentation thumbnail
Nationwide genotypic and phenotypic characterisation of homozygous familial hypercholesterolemia
Doctor C. Lin (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Clinical impact of more than 50% reduction in low-density lipoprotein cholesterol at 6 weeks after percutaneous coronary intervention for acute coronary syndrome
Doctor K. Murai (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Prevalence of elevated lipoprotein(a) [Lp(a)] in patients with familial hypercholesterolemia (FH)
Doctor J. Sawhney (New Delhi, IN)
Abstract Slides Video
Presentation thumbnail
Lipoprotein(a) lowering and risk of cardiovascular disease in primary and secondary prevention
Mr P. Kamstrup (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Lipoproteins and coronary artery disease (1)

The Event

Event poster

ESC Congress 2026

29 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Apolipoprotein B beyond LDL-cholesterol in predicting Atherosclerotic Cardiovascular Disease risk in high-risk populations
31 August 2026
thumbnail
Congress Presentation
Lipid assessment and target attainment in acute coronary syndrome: a 10-year comparative review in a UK tertiary centre.
28 August 2026
thumbnail
Congress Presentation
Case 1 - a middle-aged patient with discordant LDL-C and ApoB - integrating ApoB and non-HDL-C into routine risk assessment.
23 April 2026
thumbnail
Congress Presentation
Genetic-phenotypic discordance reveals divergent cardiovascular risk at extremes of HDL
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources